These independent CME activities are supported by educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA LLC.



Clinical Context:
Diabetes
  1. Course List
CME/CE Information

Target Audience

Endocrinologists, diabetologists, primary care physicians, nurse practitioners, nurses, physician assistants, pharmacists, and other allied healthcare professionals involved in the screening and treatment of patients with diabetes.

Activity Goal

The goal of this program is to provide case studies and data from medical meetings and journals insights at the point of care on current and emerging management strategies based on the most up-to-date evidence-based medicine and clinical trial results in diabetes.

Learning Objective (s)

  • Describe the natural history of diabetes, the importance of early diagnosis of this condition, and recent advances in our understanding of pathophysiologic mechanisms that may serve as targets of therapy.
  • Evaluate criteria that have been developed to assess treatment response in diabetes, delineate how these criteria can be used to risk-stratify patients in clinical practice, and consider therapeutic treatment options that improve patient outcomes.


CME Information: Physicians


Statement of Accreditation

Projects In Knowledge® is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

Projects In Knowledge® designates this for a maximum of 0.25 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Instructions


To obtain credit:

  1. Read or listen to each activity carefully.
  2. Complete/submit each posttest and evaluation.
  3. Instantly access and print out your certificate.

There is no fee for this activity.

CONTRACT FOR MUTUAL RESPONSIBILITY IN

Projects In Knowledge has developed the contract to demonstrate our commitment to providing the highest quality professional education to clinicians, and to help clinicians set educational goals to challenge and enhance their learning experience.

For more information on the contract, click here.
Disclosure Information

The Disclosure Policy of Projects In Knowledge® requires that all those who have control of the content of CE activities comply with the ACCME’s Standards for Commercial Support regarding disclosure of relevant financial relationships. Faculty, planners, PIK editorial scientific team, reviewers, and medical writers are required to disclose any financial relationship they or their spouse/partner have with any ACCME-defined commercial interest* relevant to the content of this activity. Any discussions of unlabeled/unapproved uses of drugs or devices will also be disclosed during the presentations.

Vivian A. Fonseca, MD, FRCP has received honoraria from Abbott Laboratories, Amgen, Astra Zeneca, Boehringer Ingelheim, Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Novo Nordisk, Inc, Pamlabs, Sanofi-aventis, and Takeda Pharmaceuticals; and has conducted contracted research for Abbott Laboratories, Asahi Kasei Pharma Corp., Eli Lilly and Company, Endo Barrier, Gilead Sciences, and Novo Nordisk, Inc.

Cyrus V. Desouza, MD, MBBS has received salary/honoraria from Takeda Pharmaceutical Company Limited; and consulting fees from Novo Nordisk.

W. Timothy Garvey, MD has received honoraria from LipoScience Inc and Merck & Co, Inc; has received consulting fees from Alkermes, Daiichi Sankyo Inc, Janssen Pharmaceuticals, Johnson & Johnson Inc, LipoScience Inc, and Vivus Inc; has conducted contracted research for Amylin Pharmaceuticals, Merck & Co, Inc, and Weight Watchers; and has ownership interest in Bristol-Myers Squibb, Eli Lilly and Company, Institute for Science and International Security, Merck & Co, Inc, Novartis Pharmaceuticals Corporation, Otsuka Pharmaceuticals, and Vivus Inc.

Carla J. Greenbaum, MD has received consulting fees from Bristol-Myers Squibb and has conducted contracted research for Janssen and Novo Nordisk.

Sandra M. Lord, MD

Anne L. Peters, MD has received salary/honoraria from AstraZeneca/Bristol-Myers Squibb and Novo Nordisk Pharmaceuticals, Inc.; and consulting fees from Abbott Diabetes Care, AstraZeneca/Bristol-Myers Squibb, Becton, Dickinson and Company, Boehringer Ingelheim, Eli Lilly and Company, Janssen Pharmaceuticals, Medtronic MiniMed, Inc., Sanofi-Aventis, and Takeda Pharmaceutical Company Limited.

Peer Reviewer has disclosed no relevant relationships.

Projects In Knowledge's staff members have no relevant relationships to disclose.

These activities may contain discussions of unlabeled/unapproved uses of drugs or devices. Specific product disclosure will be forthcoming in each activity.

The opinions expressed in these activities are those of the faculty and do not necessarily reflect those of Projects In Knowledge.

This activity is provided solely as an educational service. Specific patient care decisions are the responsibility of the clinician caring for the patient.

These independent CME activities are supported by educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA LLC.

Projects In Knowledge is a registered trademark of Projects In Knowledge, Inc.

2290